ClinicalTrials.gov
public full text
Public Domain
Lycopene in Preventing Prostate Cancer in Healthy Participants
RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development or recurrence of cancer. The dietary supplement lycopene may prevent the development of prostate cancer. PURPOSE: This phase I trial is studying the side effects and best dose of lycopene in preventing prostate cancer in healthy participants.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer#1162822
- Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer#881138
- The Effects of Lycopene on High Risk Prostatic Tissue#1058547
- Lycopene or Green Tea for Men at Risk of Prostate Cancer#862793
- Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.#857017
Record · ID 825396
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive